Atlas Trials

Head and Neck Cancer

1,618 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Head and Neck Cancer

RecordFirmDate
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer (NCT00002506)Hoag Memorial Hospital Presbyterian1992-08-01
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx (NCT00002496)Radiation Therapy Oncology Group1992-08-01
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer (NCT00002520)Eastern Cooperative Oncology Group1990-12-07
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer (NCT00002476)Cancer Research UK1990-01-01
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer (NCT00003582)University of Miami1988-05-01
S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx (NCT00002999)SWOG Cancer Research Network
Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer (NCT00080028)Pharmacyclics LLC.
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery (NCT00041171)Alliance for Clinical Trials in Oncology
A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer (NCT00496535)GenVec
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor (NCT04100694)Merus B.V.
Phase II Trial of Allovectin-7® for Head and Neck Cancer (NCT00050388)Vical
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence (NCT01142414)European Organisation for Research and Treatment of Cancer - EORTC
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies (NCT04566393)xCures
Can Cytokines Predict the Severity of Acute Mucositis and the Need for Gastrostomy Tubes (PEG)? (NCT00431925)Hadassah Medical Organization
Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer (NCT00496236)GenVec
Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck (NCT00771641)Radiation Therapy Oncology Group
Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors (NCT06872489)Second Life Therapeutics
Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker (NCT00318604)Far Eastern Memorial Hospital
← Previous

Track Head and Neck Cancer automatically

Every clearance here is in the API, with alerts when new ones post.